Genomic variants associated with cognitive impairment in Parkinson’s disease: Ethnicity-specific GWAS
Objective: We aimed to identify the genomic variants that are associated with cognitive impairment in patients with Parkinson’s disease (PD). Background: Cognitive impairment is an…Parkinsonism and rapidly progressive dementia secondary to free-living ameba
Objective: Present an original case description of a patient with amebic meningoencephalitis. Background: Parkinsonism could be caused by degenerative disorders, brain injuries, drugs, toxins, and…Social Cognition, Neuropsychological functioning & Mood Disorder in Cervical Dystonia (CD)
Objective: This study investigated social cognition, neuropsychological functioning and mood disorder in CD. Background: CD is a hyperkinetic movement disorder of unknown cause. Although historically…Cognitive Profile of Patients with Parkinson´s Disease and Subthalamic Nucleus Deep Brain Stimulation
Objective: Compare the ON and OFF cognitive performance of patients with PD receiving Subthalamic nucleus Deep Brain Stimulation (STN-DBS) using a computerized neuropsycological battery called…Verbal Disfluencies in Parkinson´s Disease Spoken Discourse as a Function of Syntax Complexity
Objective: To evaluate the effects of syntax complexity on the frequency of verbal disfluencies in individuals with PD and healthy controls (HC) during spontaneous speaking…Tau pathology is associated to cognitive and not motor function in Parkinson’s disease
Objective: To define the association of different cerebrospinal fluid (CSF) biomarkers reflecting Aß and Tau pathology or synaptic function with motor and/or cognitive function in…Synuclein-alpha´s variant, rs 894280 shows association with memory and attention in PD patients
Objective: To assess the effect of rs894280 of Sybnuclein-alpha (SNCA)gene on cognitive profile of idiopathic Parkinson’s disease (PD) patients and patterns of neuronal activity during a set-shifting…Accuracy of the MoCA in Detecting PD-MCI in the Ontario Neurodegenerative Disease Research Initiative study
Objective: To investigate the ability of the Montreal Cognitive Assessment (MoCA) to detect mild cognitive impairment (MCI) in Parkinson’s disease (PD) using variations in cognitive…Phosphodiesterase 10A and cognition in Parkinson’s disease
Objective: We aimed to assess the associations between Phosphodiesterase 10A (PDE10A) expression in the executive striatum and cognitive performance in vivo, using [11C]IMA107 PET and…The Dutch Parkinson and Cognition study (DUPARC): Cognitive impairment and cholinergic innervation in de novo Parkinson’s Disease patients
Objective: To explore the incidence and characteristics of early cognitive impairment in Parkinson’s disease (PD) patients and the relationship with regional cholinergic innervation. Background: Cognitive…
- « Previous Page
- 1
- …
- 68
- 69
- 70
- 71
- 72
- …
- 128
- Next Page »